Closing establishes footprint of the Florida-based market leader in the
Massachusetts cannabis market
CSE: TRUL
TORONTO, Dec. 13, 2018 /CNW/ - Further to its press release of
November 8, 2018, Trulieve Cannabis Corp. (CSE: TRUL) ("Trulieve" or the "Company") announced today
that it has completed the acquisition of all of the issued and outstanding shares of Life Essence, Inc. – a seed-to-sale cannabis
company with multiple locations under development in the Commonwealth of Massachusetts.
"We are very excited to have completed this important strategic acquisition," said Kim Rivers,
CEO of Trulieve. "We look forward to the diligent work ahead as we expand the Trulieve operations in order to deliver our
high-quality products and industry-leading customer service to the Massachusetts cannabis
market."
About Trulieve Cannabis Corp.
Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis
company in the State of Florida. Trulieve cultivates and produces all of its products in-house
and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of
Florida, as well as directly to patients via home delivery. Trulieve is listed on the Canadian Securities Exchange under
the symbol TRUL.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of
any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Forward-Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited to, information
and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans,
intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the Company's plans
for the assets acquired. Words such as "expects", "continue", "will", "anticipates" and "intends" or similar expressions
are intended to identify forward-looking statements. These forward-looking statements are based on the Company's current
projections and expectations about future events and financial trends that management believes might affect its financial
condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the
Company in light of the experience and perception of historical trends, current conditions and expected future developments and
other factors management believes are appropriate. Forward-looking information and statements involve and are subject to
assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or
achievements of the Company to be materially different from future events, results, performance, and achievements expressed or
implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information
and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in
such information and statements, there can be no assurance that any such forward-looking information and statements will prove to
be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not
place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein
are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any
intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events
or results could or do differ from those projected in any forward looking information and statements herein, whether as a result
of new information, future events or results, or otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
SOURCE Trulieve Cannabis Corp.
View original content: http://www.newswire.ca/en/releases/archive/December2018/13/c6884.html